Found: 50
Select item for more details and to access through your institution.
Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active Melanoma.
- Published in:
- Case Reports in Oncological Medicine, 2019, p. 1, doi. 10.1155/2019/4683531
- By:
- Publication type:
- Article
Renal Cell Carcinoma presenting with peritoneal metastasis.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
A self destructing reaction to a self destructive habit: Levamisole tainted cocaine causing autoimmune vasculitis.
- Published in:
- New York Medical Journal (2154-9400), 2014, v. 8, n. 1, p. 1
- By:
- Publication type:
- Article
Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/1856594
- By:
- Publication type:
- Article
Treatment Patterns, Clinical Outcomes, Health Care Resource Utilization and Costs in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the United States: An Analysis of SEER-Medicare Data.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 5, p. 517, doi. 10.1016/j.clgc.2023.04.014
- By:
- Publication type:
- Article
Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies.
- Published in:
- Antibiotics (2079-6382), 2020, v. 9, n. 11, p. 740, doi. 10.3390/antibiotics9110740
- By:
- Publication type:
- Article
PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic Landscape.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 2, p. 198, doi. 10.3390/life14020198
- By:
- Publication type:
- Article
Landmark Series on Disparities in Surgical Oncology: Melanoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 6986, doi. 10.1245/s10434-021-10273-x
- By:
- Publication type:
- Article
Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer.
- Published in:
- Drugs, 2021, v. 81, n. 2, p. 191, doi. 10.1007/s40265-020-01456-z
- By:
- Publication type:
- Article
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12260-3
- By:
- Publication type:
- Article
Ipilimumab-induced hypophysitis, a single academic center experience.
- Published in:
- Pituitary, 2019, v. 22, n. 5, p. 488, doi. 10.1007/s11102-019-00978-4
- By:
- Publication type:
- Article
A Retrospective Analysis of Clinical Trial Accrual of Patients Presented in a Multidisciplinary Tumor Board at a Tertiary Health Care Center and Associated Barriers.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 196, doi. 10.1159/000506840
- By:
- Publication type:
- Article
Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2143, doi. 10.3390/cancers16112143
- By:
- Publication type:
- Article
Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural Areas.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5171, doi. 10.3390/cancers15215171
- By:
- Publication type:
- Article
Enhancing Triage Efficiency and Accuracy in Emergency Rooms for Patients with Metastatic Prostate Cancer: A Retrospective Analysis of Artificial Intelligence-Assisted Triage Using ChatGPT 4.0.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3717, doi. 10.3390/cancers15143717
- By:
- Publication type:
- Article
Treatment Pattern and Outcomes with Systemic Therapy in Men with Metastatic Prostate Cancer in the Real-World Patients in the United States.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4951, doi. 10.3390/cancers13194951
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors in Prostate Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2187, doi. 10.3390/cancers13092187
- By:
- Publication type:
- Article
Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1489, doi. 10.3390/cancers13071489
- By:
- Publication type:
- Article
A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas.
- Published in:
- Cancers, 2018, v. 10, n. 2, p. 53, doi. 10.3390/cancers10020053
- By:
- Publication type:
- Article
Eribulin in Cancer Treatment.
- Published in:
- Marine Drugs, 2015, v. 13, n. 8, p. 5016, doi. 10.3390/md13085016
- By:
- Publication type:
- Article
Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG 1216 Phase 3 Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 8, p. e2326546, doi. 10.1001/jamanetworkopen.2023.26546
- By:
- Publication type:
- Article
A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1229823
- By:
- Publication type:
- Article
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prior Local Therapy and First-Line Apalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of the SPARTAN Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 10, p. e2439434, doi. 10.1001/jamanetworkopen.2024.39434
- By:
- Publication type:
- Article
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 7, p. e2423186, doi. 10.1001/jamanetworkopen.2024.23186
- By:
- Publication type:
- Article
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 7, p. e2419966, doi. 10.1001/jamanetworkopen.2024.19966
- By:
- Publication type:
- Article
Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials: A Meta-Analysis.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 7, p. e2421485, doi. 10.1001/jamanetworkopen.2024.21485
- By:
- Publication type:
- Article
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e249417, doi. 10.1001/jamanetworkopen.2024.9417
- By:
- Publication type:
- Article
Clinical, Genomic, and Transcriptomic Characteristics of Patients with Metastatic Renal Cell Carcinoma Who Developed Thromboembolic Events.
- Published in:
- Journal of Kidney Cancer & VHL, 2024, v. 11, n. 3, p. 1, doi. 10.15586/jkcvhl.v11i3.319
- By:
- Publication type:
- Article
Detection of BRCA1 , and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting.
- Published in:
- Biomedicines, 2022, v. 10, n. 12, p. 3170, doi. 10.3390/biomedicines10123170
- By:
- Publication type:
- Article
Effectiveness of ChatGPT 4.0 in Telemedicine-Based Management of Metastatic Prostate Carcinoma.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 17, p. 1899, doi. 10.3390/diagnostics14171899
- By:
- Publication type:
- Article
Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 3741, doi. 10.2147/CMAR.S202973
- By:
- Publication type:
- Article
Natural course of metastatic castration‐resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone‐sensitive setting.
- Published in:
- Prostate, 2024, v. 84, n. 9, p. 888, doi. 10.1002/pros.24696
- By:
- Publication type:
- Article
Impact of androgen receptor alterations on cell‐free DNA genomic profiling on survival outcomes in metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 16, p. 1602, doi. 10.1002/pros.24618
- By:
- Publication type:
- Article
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR).
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. 450, doi. 10.1093/oncolo/oyae030
- By:
- Publication type:
- Article
Impact of Time to Metastasis (Synchronous vs. Metachronous) on Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with First Line Immune-Checkpoint Inhibitors (ICI)-based Combinations.
- Published in:
- Oncologist, 2023, v. 28, p. S9, doi. 10.1093/oncolo/oyad216.014
- By:
- Publication type:
- Article
The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World Practice.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 746, doi. 10.1093/oncolo/oyad047
- By:
- Publication type:
- Article
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 737, doi. 10.1093/oncolo/oyad019
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
- Published in:
- Oncologist, 2022, v. 27, n. 10, p. e815, doi. 10.1093/oncolo/oyac176
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
- Published in:
- Oncologist, 2022, v. 27, n. 9, p. e815, doi. 10.1093/oncolo/oyac176
- By:
- Publication type:
- Article
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 220, doi. 10.1093/oncolo/oyab057
- By:
- Publication type:
- Article
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1006, doi. 10.1002/onco.13949
- By:
- Publication type:
- Article
Identification of Somatic Gene Signatures in Circulating Cell‐Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 751, doi. 10.1002/onco.13869
- By:
- Publication type:
- Article
The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin‐Ineligible Patients with Muscle‐Invasive Localized Urothelial Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 5, p. 580, doi. 10.1634/theoncologist.2019-0161
- By:
- Publication type:
- Article
Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.966534
- By:
- Publication type:
- Article
Harnessing DNA Replication Stress for Novel Cancer Therapy.
- Published in:
- Genes, 2020, v. 11, n. 9, p. 990, doi. 10.3390/genes11090990
- By:
- Publication type:
- Article
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2621, doi. 10.1002/cncr.35302
- By:
- Publication type:
- Article
Experience With Vena Cava Filters at a Large Community Hospital and Level-I Trauma Center: Indications, Complications, and Compliance Barriers.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2014, v. 20, n. 5, p. 546, doi. 10.1177/1076029613505766
- By:
- Publication type:
- Article
Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma.
- Published in:
- OncoTargets & Therapy, 2022, v. 15, p. 1047, doi. 10.2147/OTT.S318332
- By:
- Publication type:
- Article
Prostate Cancer Breaking News: ASCO 2022.
- Published in:
- AUANews, 2022, v. 27, n. 9, p. 33
- By:
- Publication type:
- Article